Find out how to deal online from £1.50 in a SIPP, ISA or Dealing Account.
Jump to:

Allergy Therapeutics Fundamentals

Company Name Allergy Therapeutics Last Updated 22 Aug 2019
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 636.17 Market Cap (£m) 73.48
PE Ratio -9.09 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS -1.27 EPS Growth (%) -202.38
PEG 0.04 DPS Growth (%) n/a
Debt Ratio 36.69 Debt Equity Ratio 0.48
Net Gearing 24.40 Gross Gearing 54.85
Asset Equity Ratio 2.22 Cash Equity Ratio 67.44
Quick Ratio 1.51 Current Ratio 2.11
Price To Book Value 3.19 ROCE -18.96

Allergy Therapeutics Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Allergy Therapeutics Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 10 10 10
Intangible Assets 5 5 5
Investments 5 5 4
Total Fixed Assets 20 20 19
Stocks 9 7 8
Debtors 7 8 7
Cash & Equivalents 16 22 23
Other Assets 0 0 0
Total Assets 51 57 57
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 15 14 13
Creditors after 1 year 13 13 14
Other Liabilities 0 0 0
Total Liabilities 28 27 26
Net assets 23 30 30
Equity (£m) 2018 2017 2016
Called up share capital 1 1 1
Share Premium 102 102 102
Profit / Loss -7 -2 -12
Other Equity 42 41 41
Preference & Minorities 0 0 0
Total Capital Employed 23 30 30
Ratios 2018 2017 2016
Debt Ratio 36.69 30.58 31.33
Debt-to-Equity 0.48 0.49 0.53
Net Gearing 24.40 8.91 5.20
Gross Gearing 54.85 47.60 46.50
Assets / Equity 2.22 1.91 1.87
Cash / Equity 67.44 73.83 77.19
EPS -1.27 -0.42 -2.29
Cash Flow (£m) 2018 2017 2016
Cash from operating activities -4 0 -12
Cashflow before financing -6 -2 -13
Increase in Cash -7 -2 -1
Income (£m) 2018 2017 2016
Turnover 68 64 49
Cost of sales 17 17 14
Gross Profit 51 47 34
Operating Profit -7 -2 -12
Pre-Tax profit -7 -2 -12
Profit / Loss for the year 1 1 1

Allergy Therapeutics Company Background

Sector Pharmaceuticals
Activities Allergy Therapeutics plc is an international specialty pharmaceutical group focussed on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development. Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics is headquartered in Worthing, UK.
Latest Interim Date 06 Mar 2019
Latest Fiscal Year End Date 26 Sep 2018

Allergy Therapeutics Directors

Appointed Director Position
01 Sep 2009 Manuel Llobet Chief Executive Officer
09 Jun 2016 Nicolas Alexander Ulrich Wykeman Finance Director
30 Sep 2010 Peter Sinclair Jensen Non-Executive Chairman
19 Jun 2019 Mary Geraldine Tavener Non-Executive Director
06 Jun 2017 Dr Babatunde Adekunle Otulana Non-Executive Director
08 Sep 2004 Stephen Rushworth Smith Non-Executive Director
07 Nov 2018 Scott Michael Leinenweber Non-Executive Director

Allergy Therapeutics Contact Details

Company Name Allergy Therapeutics
Company Address Dominion Way, Worthing, West Sussex BN14 8SA.
Company Telephone +44 (0)1903 844 700
Company Website http://www.allergytherapeutics.com/

Allergy Therapeutics Advisors

Auditor Name Grant Thornton UK LLP
Auditor Address The Explorer Building, Fleming Way, Manor Royal, Gatwick RH10 9GT
Auditor Website http://www.grant-thornton.co.uk/
Auditor Telephone +44 (0)870 381 7000
Registrar Name Capita Registrars
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.capitaregistrars.com/
Registrar Telephone 0870 162 3100
Broker Name Panmure Gordon & Co
Broker Address One New Change, London EC4M 9AF.
Broker Website http://www.panmure.com/
Broker Telephone +44 (0)20 7886 2500
Adviser Name Panmure Gordon & Co
Adviser Address One New Change, London EC4M 9AF.
Adviser Website http://www.panmure.com/
Adviser Telephone +44 (0)20 7886 2500
Solicitor Name Berwin Leighton Paisner LLP
Solicitor Address Adelaide House, London Bridge, London EC4R 9HA.
Solicitor Website http://www.blplaw.com/
Solicitor Telephone +44 (0)20 7760 1000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a